| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Walter Marc Hertz | Chief Executive Officer | 0 | 0 | 0 | 52.6% | 24 Apr, 2023 |
| 2 | Albert Agro | Chief Medical Officer | 0 | 0 | 0 | 22.8% | 24 Apr, 2023 |
| 3 | Vipin Chaturvedi | Chief Scientific Officer | 0 | 0 | 0 | 22.8% | 24 Apr, 2023 |
| 4 | Marella Thorell | Director | 0 | 0 | 0 | 1.8% | 14 Dec, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 18 Sep, 2025 | David Charles Baker | Director | Acquired A | 23,605 | $0.00 | $0 | 843 | Direct |
| 18 Sep, 2025 | Camilla V Simpson | Director | Acquired A | 23,605 | $0.00 | $0 | 843 | Direct |
| 18 Sep, 2025 | David Leslie Szekeres | Director | Acquired A | 39,897 | $0.00 | $0 | 1,425 | Direct |
| 18 Sep, 2025 | Leanne Kelly | Chief Financial Officer | Acquired A | 43,222 | $0.00 | $0 | 1,543 | Direct |
| 18 Sep, 2025 | Vipin Chaturvedi | Chief Scientific Officer | Acquired A | 43,222 | $0.00 | $0 | 1,543 | Direct |
| 18 Sep, 2025 | Roelof Rongen | Director | Acquired A | 23,605 | $0.00 | $0 | 843 | Direct |
| 18 Sep, 2025 | Walter Marc Hertz | Chief Executive Officer | Acquired A | 103,067 | $0.00 | $0 | 3,681 | Direct |
| 26 Aug, 2025 | Walter Marc Hertz | Chief Executive Officer | Acquired A | 26,688 | $0.00 | $0 | 953 | Direct |
| 26 Aug, 2025 | David Charles Baker | Director | Acquired A | 5,994 | $0.00 | $0 | 214 | Direct |
| 26 Aug, 2025 | Leanne Kelly | Chief Financial Officer | Acquired A | 11,854 | $0.00 | $0 | 423 | Direct |
| 26 Aug, 2025 | David Leslie Szekeres | Director | Acquired A | 10,276 | $0.00 | $0 | 367 | Direct |
| 26 Aug, 2025 | Roelof Rongen | Director | Acquired A | 5,994 | $0.00 | $0 | 214 | Direct |
| 26 Aug, 2025 | Camilla V Simpson | Director | Acquired A | 5,994 | $0.00 | $0 | 214 | Direct |
| 26 Aug, 2025 | Vipin Chaturvedi | Chief Scientific Officer | Acquired A | 11,854 | $0.00 | $0 | 423 | Direct |
| 13 Aug, 2025 | Roelof Rongen | Director | Acquired A | 4,527 | $0.00 | $0 | 162 | Direct |
| 13 Aug, 2025 | David Charles Baker | Director | Acquired A | 4,527 | $0.00 | $0 | 162 | Direct |
| 13 Aug, 2025 | David Leslie Szekeres | Director | Acquired A | 7,545 | $0.00 | $0 | 269 | Direct |
| 13 Aug, 2025 | Camilla V Simpson | Director | Acquired A | 4,527 | $0.00 | $0 | 162 | Direct |
| 23 Jan, 2025 | David Leslie Szekeres | Director | Acquired A | 51,937 | $326.45 | $16.95Mn | 109 | Direct |
| 23 Jan, 2025 | Walter Marc Hertz | Chief Executive Officer | Acquired A | 129,730 | $326.45 | $42.35Mn | 272 | Direct |